Literature DB >> 15845432

Corynebacterium striatum: an underappreciated community and nosocomial pathogen.

Prescott P Lee1, Donald A Ferguson, Felix A Sarubbi.   

Abstract

Corynebacterium striatum (CS) is an underappreciated human pathogen that has been associated with serious infections in both immunocompetent and immunocompromised hosts. CS infections tend to be more frequent in males and major infection sites have included blood stream, lung, and central nervous system. Most are nosocomially acquired and there is a significant association with medical devices ranging from intravascular catheters to central nervous system drainage devices. Empiric therapy with vancomycin is advisable as susceptibility to other agents is variable. Treatment may also include removal of foreign material such as an intravascular catheter. The present review describes the wide spectrum of infections associated with CS and we add a unique case of CS pancreatic abscess where treatment included linezolid.

Entities:  

Mesh:

Year:  2005        PMID: 15845432     DOI: 10.1016/j.jinf.2004.05.005

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  25 in total

1.  Native valve endocarditis caused by Corynebacterium striatum with heterogeneous high-level daptomycin resistance: collateral damage from daptomycin therapy?

Authors:  Truc T Tran; Siraya Jaijakul; Cole T Lewis; Lorena Diaz; Diana Panesso; Heidi B Kaplan; Barbara E Murray; Audrey Wanger; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

2.  A spontaneous joint infection with Corynebacterium striatum.

Authors:  David Scholle
Journal:  J Clin Microbiol       Date:  2006-12-06       Impact factor: 5.948

3.  A case of fatal sepsis due to multidrug-resistant Corynebacterium striatum.

Authors:  M Chatzopoulou; T Koufakis; I Voulgaridi; I Gabranis; M Tsiakalou
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

4.  Toll-Like Receptor 2 and Mincle Cooperatively Sense Corynebacterial Cell Wall Glycolipids.

Authors:  Judith Schick; Philipp Etschel; Rebeca Bailo; Lisa Ott; Apoorva Bhatt; Bernd Lepenies; Carsten Kirschning; Andreas Burkovski; Roland Lang
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

5.  AAC(3)-XI, a new aminoglycoside 3-N-acetyltransferase from Corynebacterium striatum.

Authors:  Marc Galimand; Jennifer Fishovitz; Thierry Lambert; Valérie Barbe; Jaroslav Zajicek; Shahriar Mobashery; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

6.  Pacemaker lead endocarditis due to multidrug-resistant Corynebacterium striatum detected with sonication of the device.

Authors:  Alessandra Oliva; Valeria Belvisi; Marco Iannetta; Carolina Andreoni; Maria T Mascellino; Miriam Lichtner; Vincenzo Vullo; Claudio M Mastroianni
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

7.  Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary tale.

Authors:  E McElvania TeKippe; B S Thomas; G A Ewald; S J Lawrence; C-A D Burnham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-28       Impact factor: 3.267

8.  Emergence of High-Level Daptomycin Resistance in Corynebacterium striatum in Two Patients with Left Ventricular Assist Device Infections.

Authors:  Brian J Werth; William O Hahn; Susan M Butler-Wu; Robert M Rakita
Journal:  Microb Drug Resist       Date:  2015-11-06       Impact factor: 3.431

9.  Corynebacterium endocarditis species-specific risk factors and outcomes.

Authors:  Jaime Belmares; Stephanie Detterline; Janet B Pak; Jorge P Parada
Journal:  BMC Infect Dis       Date:  2007-02-06       Impact factor: 3.090

10.  Importance of Coryneform Bacteria in Infective Endocarditis.

Authors:  Alexander von Graevenitz
Journal:  Infect Dis Rep       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.